Successful treatment of refractory lung adenocarcinoma harboring a germline <i>BRCA2</i> mutation with olaparib: A case report
2021 · World Journal of Clinical Cases · 13 citations
https://doi.org/10.12998/wjcc.v9.i25.7498
L
Lingzhi Cui
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
24
Citations
2
h-index
1
i10-index
Lingzhi Cui is an academic researcher from ShenZhen People’s Hospital. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Colorectal Cancer Treatments and Studies & Genetic factors in colorectal cancer. The author has an h-index of 2, co-authored 9 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat